Summer Sale
50% off Premium Yearly
00days
00hrs
00mins
00secs
Opinions Jean-Francois Tardif
Syneron Medical Ltd.ELOSTOP PICKFeb 03, 2005
Health and cosmetic industry is growing very strong. Company is very innovative. In '04, their earnings grew about 100%. Have $3 cash per share. Will be launching a new product for sunlight. Trades at 25 X current earnings.
Jean-Francois TardifOwned
$29.00
Stock price when the opinion was issued
biotechnologypharmaceutical
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.
You might be interested:
PAST TOP PICK
(A Top Pick Feb 15/06. Down 27%.) Disappointed two quarters in a row. Forward expectations by US analysts have dropped. Have sold some shares. The industry is doing well. He'll wait for one more quarter.
Jean-Francois TardifOwned
biotechnologypharmaceutical
WATCH
Still likes it, but there are some worrisome things. Have lost some top level management. The earnings are growing, have a great balance sheet and lots of cash. Waiting to see what the next quarter brings. Trading around 10 X earnings which is not expensive.
Jean-Francois TardifOwned
biotechnologypharmaceutical
PAST TOP PICK
(A Top Pick Feb 15/06. Up 6%.) The beauty treatment sector is doing very well. Still likes.
Jean-Francois TardifOwned
biotechnologypharmaceutical
TOP PICK
Recently, the stock was hit pretty hard because of lower than expected earnings forecast. Thinks they will make $2/2.20 a share in ’06. They have $5 in cash per share. Not very expensive.
Jean-Francois TardifOwned
biotechnologypharmaceutical
TOP PICK
Sells machines to health care clinics. Just got approval from the FDA for a cellulite product. Expects great demand. Earnings have been rising very rapidly. Low multiples.
Jean-Francois TardifOwned
biotechnologypharmaceutical
PAST TOP PICK
(A Top Pick Feb3/05. Up 20%.) Still likes. Trying to get approval on a new product. Analysts forcast for next year is $1.60 but he believes it could be as high as $2.50/3.00.
Jean-Francois TardifOwned
biotechnologypharmaceutical
